J.P. Morgan lowered forecasts for the U.S. and global knee and hip market, which means the third quarter forecasts for these companies is also low. The price target for Stryker decreased from $58 to $49, Zimmer from $63 to $58 and Wright from $21 to $17.
Read the Benzinga report on J.P. Morgan’s lowered forecasts.
Read other coverage on orthopedic device companies:
– VertiFlex Sells Silverbolt Product Portfolio to Exatech
– Stryker Acquires Gaymar Industries
